Evidence map›Paper›PMID 42136856›Full record

ArticleFrontiers in medicine2026

Integrating single-cell RNA-seq and machine learning to dissect polyamine metabolism in metabolic dysfunction-associated steatotic liver disease.

Peng Zou, Lin Sun, Zhibin Lin

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Peng Zou *Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Lin Sun *Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Zhibin LinDepartment of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dysregulated immunometabolism is central to the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD). Although polyamines contribute to cellular stress responses and immune-cell function, their cell-type-specific transcriptional associations within the hepatic immune microenvironment remain incompletely understood. Methods: We assessed polyamine metabolism in MASLD at the single-cell level using AUCell, UCell, singscore, and AddModuleScore. To find metabolism-related genes, we performed differential analyses. We then combined six machine learning methods-including LASSO, Random Forest, XGBoost, GBM, SVM, and Boruta-to identify and sort robust disease genes. We further evaluated these findings using bulk transcriptomic datasets and a CDAA-induced MASH mouse model. Results: We observed notable differences in polyamine metabolic activity among various liver cell types, with relatively higher levels detected in macrophages, cholangiocytes, and stromal cells. PSMB7 and PSMD7 emerged as proteasome-associated candidate genes that were enriched in macrophages and upregulated in MASLD. Higher expression of these genes was associated with immune-related transcriptional programs, including antigen-processing/presentation signatures and predicted intercellular communication pathways involving MIF- and TNFSF13B-related signaling. Their upregulation was further supported by bulk RNA analyses and the CDAA-induced MASH model. Conclusion: Our single-cell analysis showed clear heterogeneity in polyamine-metabolism-related states in MASLD, with macrophages emerging as a major associated cell population. PSMB7 and PSMD7 emerged as proteasome-associated candidate markers enriched in macrophage populations with elevated polyamine-metabolism scores, providing a framework for future mechanistic investigation.

Indexed as

machine learningmacrophagemetabolic dysfunction-associated steatotic liver diseasepolyamine metabolismsingle-cell RNA sequencing

Identifiers

PMID42136856
PMCPMC13167413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.